A proposed deal for Purdue Pharma LP to resolve more than 2,000 lawsuits over its role in the opioid crisis is facing pushback from a vocal group of state attorneys general who say it doesn’t bring in enough cash to satisfy their demands, according to people familiar with the matter.

from MarketWatch.com - Top Stories https://ift.tt/2NL2XoR
from MarketWatch.com - Top Stories https://ift.tt/2NL2XoR
Comments
Post a Comment